IGC Pharma (IGC) Other Working Capital Changes (2010 - 2025)
IGC Pharma (IGC) posted quarterly Other Working Capital Changes of $19000.0 for Q3 2025, up 155.88% year-over-year from $7425.3 in Q3 2024, and up 179.17% quarter-over-quarter from -$24000.0 in Q2 2025.
IGC Pharma (IGC) Other Working Capital Changes (2010 - 2025) Analysis & Trends
IGC Pharma (IGC) has reported Other Working Capital Changes for 12 consecutive years, with $19000.0 the latest figure, recorded in Q3 2025.
- In Q3 2025, Other Working Capital Changes rose 155.88% year-over-year to $19000.0; the TTM figure through Sep 2025 stood at -$26000.0 (up 76.58% YoY), while the FY2026 annual figure was $20000.0, up 127.03% from the prior year.
- Other Working Capital Changes advanced to $19000.0 in Q3 2025 per IGC's latest filing, from -$24000.0 in the prior quarter.
- Across five years, Other Working Capital Changes topped out at $441000.0 in Q4 2022 and bottomed at -$727000.0 in Q1 2022.
- Historically, Other Working Capital Changes has averaged -$53684.2 across 5 years, with a median of -$32000.0 in 2025.
- Annual changes were most pronounced in 2022 — Other Working Capital Changes slumped 217.86% — and 2025, when it surged 155.88%.
- IGC Pharma's Other Working Capital Changes stood at -$30000.0 in 2021, then declined by 13.33% to -$34000.0 in 2022, then grew by 8.82% to -$31000.0 in 2023, then increased by 25.81% to -$23000.0 in 2024, then surged by 182.61% to $19000.0 in 2025.
- Business Quant data shows IGC's Other Working Capital Changes at $19000.0 in Q3 2025, -$24000.0 in Q2 2025, and $2000.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn |
| 10 | IGC Pharma | 27.20 Mn | 26.94 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -53,000.00 |
| Sep 30, 2025 | -53,000.00 |
| Sep 30, 2025 | -53,000.00 |
| Jun 30, 2025 | -32,000.00 |
| Jun 30, 2025 | -32,000.00 |
| Jun 30, 2025 | -32,000.00 |
| Mar 31, 2025 | -31,000.00 |
| Mar 31, 2025 | -31,000.00 |
| Mar 31, 2025 | -31,000.00 |
| Dec 31, 2024 | 227,000.00 |
| Dec 31, 2024 | 227,000.00 |
| Dec 31, 2024 | 227,000.00 |
| Sep 30, 2024 | -155,000.00 |
| Sep 30, 2024 | -155,000.00 |
| Sep 30, 2024 | -155,000.00 |
| Jun 30, 2024 | 118,000.00 |
| Jun 30, 2024 | 118,000.00 |
| Jun 30, 2024 | 118,000.00 |
| Mar 31, 2024 | 40,000.00 |
| Mar 31, 2024 | 40,000.00 |